Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Granulocyte Infusion in Advanced Cancer
NCT04124666Phase 2Unknown
- Sponsor
- Shanghai East Hospital
- Start
- Dec 2019
- Primary completion
- Sep 2022
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of granulocytes in cancer, sponsored by Shanghai East Hospital. Status: unknown.
02
Drugs
granulocytes
03
Conditions
cancer
Beyond the preview
Go deeper on NCT04124666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04124666.